Skip to main content

Advertisement

Log in

Intriguing information from recent letter and article regarding unwanted targeting of salivary glands by PSMA ligands

  • Letter to the Editor
  • Published:
European Journal of Nuclear Medicine and Molecular Imaging Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Data Availability

The reconstructed microPET images and detailed biodistrubtion data are available upon request.

References

  1. Lucaroni L, Georgiev T, Prodi E, Puglioli S, Pellegrino C, Favalli N, et al. Cross-reactivity to glutamate carboxypeptidase III causes undesired salivary gland and kidney uptake of PSMA-targeted small-molecule radionuclide therapeutics. Eur J Nucl Med Mol Imaging. 2023;50:957–61. https://doi.org/10.1007/s00259-022-05982-8.

    Article  CAS  PubMed  Google Scholar 

  2. Lee Z, Heston WD, Wang X, Basilion JP. GCP III is not the “off-target” for urea-based PSMA ligands. Eur J Nucl Med Mol Imaging. 2023. https://doi.org/10.1007/s00259-023-06265-6.

    Article  PubMed  Google Scholar 

  3. Rousseau E, Lau J, Kuo HT, Zhang Z, Merkens H, Hundal-Jabal N, et al. Monosodium glutamate reduces (68)Ga-PSMA-11 uptake in salivary glands and kidneys in a preclinical prostate cancer model. J Nucl Med. 2018;59:1865–8. https://doi.org/10.2967/jnumed.118.215350.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Roy J, Warner BM, Basuli F, Zhang X, Wong K, Pranzatelli T, et al. Comparison of prostate-specific membrane antigen expression levels in human salivary glands to non-human primates and rodents. Cancer Biother Radiopharm. 2020;35:284–91. https://doi.org/10.1089/cbr.2019.3079.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Huang SS, Wang X, Zhang Y, Doke A, DiFilippo FP, Heston WD. Improving the biodistribution of PSMA-targeting tracers with a highly negatively charged linker. Prostate. 2014;74:702–13. https://doi.org/10.1002/pros.22789.

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

This work was funded by Ohio Department of Development, Ohio Third Frontier TVSF grant TECH 2015–0779 and 2017–0053.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Steve S. Huang.

Ethics declarations

Ethics approval

Animal experiments using mice were performed in accordance with recommendations in Guide for the Care and Use of Laboratory Animals of the National Institutes of Health and conducted under a protocol approved by Cleveland Clinic Institutional Animal Care and Use Committee. Studies were supported in part by the Case Comprehensive Cancer Center Athymic Animal and Preclinical Therapeutics Shared Resource and NCI core grant 5 P30 CA043703-32. Studies were performed under CCF IACUC2464.

Conflict of interest

Steve Huang filed a patent application with Cleveland Clinic Innovations regarding JB-1498. All other authors declare no conflict of interest.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Huang, S.S., DiFilippo, F., Lindner, D. et al. Intriguing information from recent letter and article regarding unwanted targeting of salivary glands by PSMA ligands. Eur J Nucl Med Mol Imaging 50, 2950–2951 (2023). https://doi.org/10.1007/s00259-023-06325-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00259-023-06325-x

Navigation